Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiao-Yong Fan

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Frontiers in Microbiology|October 24, 2022
Editorial: Novel approaches to rapid diagnosis and treatment monitoring of active tuberculosis, vol IIZhidong Hu, Xiao-Yong Fan
Emerging Microbes & Infections|May 26, 2021
Where are the RNA vaccines for TB?Xiao-Yong Fan, Douglas Bruce Lowrie
NPJ Vaccines|October 31, 2024
Immune correlates of protection as a game changer in tuberculosis vaccine developmentJing Wang, Xiao-Yong Fan, Zhidong Hu
The Journal of Infectious Diseases|December 25, 2019
Statins as Adjunctive Therapy Against Tuberculosis (TB): The Balance Between Statin-Induced Anti-TB Effect and Trained Immunity SuppressionZhidong Hu, Douglas B Lowrie, Xiao-Yong Fan
The Journal of Infectious Diseases|May 31, 2018
Reply to MahlaZhidong Hu, Douglas B Lowrie, Xiao-Yong Fan
STAR Protocols|August 18, 2024
Protocol for analyzing BCG-induced trained immunity in murine bone marrow-derived macrophagesJin-Chuan Xu, Zhidong Hu, Xiao-Yong Fan
Frontiers in Immunology|February 7, 2024
Editorial: Innate and adaptive immunity against tuberculosis infection: diagnostics, vaccines, and therapeuticsZhidong Hu, Lanbo Shi, Jianping Xie, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 3, 2024
Natural products in anti-tuberculosis host-directed therapyXuejiao Huang, Douglas B Lowrie, Xiao-Yong Fan, et al.
Frontiers in Microbiology|October 21, 2022
Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against <i>Mycobacterium tuberculosis</i> in miceJuan Wu, Zhidong Hu, Shui-Hua Lu, et al.
Medcomm|March 14, 2022
Trained immunity: A Yin-Yang balanceZhidong Hu, Shui-Hua Lu, Douglas B Lowrie, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Frontiers in Microbiology|October 24, 2022
Editorial: Novel approaches to rapid diagnosis and treatment monitoring of active tuberculosis, vol IIZhidong Hu, Xiao-Yong Fan
Emerging Microbes & Infections|May 26, 2021
Where are the RNA vaccines for TB?Xiao-Yong Fan, Douglas Bruce Lowrie
NPJ Vaccines|October 31, 2024
Immune correlates of protection as a game changer in tuberculosis vaccine developmentJing Wang, Xiao-Yong Fan, Zhidong Hu
The Journal of Infectious Diseases|December 25, 2019
Statins as Adjunctive Therapy Against Tuberculosis (TB): The Balance Between Statin-Induced Anti-TB Effect and Trained Immunity SuppressionZhidong Hu, Douglas B Lowrie, Xiao-Yong Fan
The Journal of Infectious Diseases|May 31, 2018
Reply to MahlaZhidong Hu, Douglas B Lowrie, Xiao-Yong Fan
STAR Protocols|August 18, 2024
Protocol for analyzing BCG-induced trained immunity in murine bone marrow-derived macrophagesJin-Chuan Xu, Zhidong Hu, Xiao-Yong Fan
Frontiers in Immunology|February 7, 2024
Editorial: Innate and adaptive immunity against tuberculosis infection: diagnostics, vaccines, and therapeuticsZhidong Hu, Lanbo Shi, Jianping Xie, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 3, 2024
Natural products in anti-tuberculosis host-directed therapyXuejiao Huang, Douglas B Lowrie, Xiao-Yong Fan, et al.
Frontiers in Microbiology|October 21, 2022
Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against <i>Mycobacterium tuberculosis</i> in miceJuan Wu, Zhidong Hu, Shui-Hua Lu, et al.
Medcomm|March 14, 2022
Trained immunity: A Yin-Yang balanceZhidong Hu, Shui-Hua Lu, Douglas B Lowrie, et al.
Pageof 10